A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Clinical trial NCT04210219 · COMPLETED

Trial details

NCT number: NCT04210219
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2020-07-02
Primary completion: 2025-05-28
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.